IMO this top down approach by current management shows a total lack of imagination and money. First the technology should be available to the public in the form of a device that is sold at every drug store, on line retailer , etc. for something like $49.95 , they would sell millions worldwide. obviously a scaled down version used for periodical use and recommends seeing a Derm. if necessary. The Derms, hospitals, etc get the 3d top of line machine with all the benefits and advantages . The money generating ability of the technology and patents are staggering in the rite hands. I still believe this is being played by the money people and current stockholders are getting royally screwed .
could be early investors trading around their positions, taking profits, shaking out weak hands, and buying back at reduced profits. welcome to early stage, speculative investing.
will be like treading water for the stock price if management doesn't address the lack of revenue generation. Management needs to present a credible timeline showing revenue generation over the next year or two. Currently they have dropped the ball in this regard, it's hard putting a value on CGIX at the present time and without input this stock could go much lower, IMO. News/rumors/speculation could move the price greatly higher or lower at a moments notice, time for management to get proactive vs reactive.
numbers, how is QFOR not trading at over $1 ps at present ?
Ent. value $69m vs market value $59m
forward p/e 5.4
rev growth 31%+
l/f cash flow $2.5m
A first to market position in a multi billion $ market.
I believe CGIX is proceeding as they have projected from past calls and we are presently experiencing a shakeout of weak hands in the stock price. If clinical sales are as they state and will appear in the next quarter we might be experiencing a good buying opportunity during the next week or so.
Having heard the Analysts meeting and seen the quarters numbers, $4.2 cash/equv. on hand and $4.3 operating loss for quarter, I still have the same question for management. Where is the business plan? With revenue of $225k a quarter and no plan to grow that anytime soon, anybody care to venture what happens to present stockholders? Has anybody seen a business pro forma / plan ? Anything that has a timeline for revenue generation ? Any interest of buyout , partnering , sale , anything ?
All I'm seeing is the present financiers bleeding this company for the next year or so and taking it private just prior to Insurance reimbursement acceptance......................
The market will soon realize this is a real company with real earnings and a future. The market value will then reach and exceed the enterprise value which is 22%+ higher at the present time. With the last quarter in the books this gap should no longer exist IMO.
As I believe in the device, with FDA approval, concept . technology etc . I have averaged to a sub $3.15 cost basis. I will not, and haven't in awhile, added to that position, and as opportunities present themselves will sell off shares. Until management proves capable of acting in a shareholder compatable manner and understands their fiduciary responsibilities one must be realistic and be prepared for all possible outcomes . As I have stated in past posts this has, and has all the markings, at present, of being my yearly tax loss for quite awhile. I continue to believe that the value of patent, etc. is north of $4 per share at present. I could go on and on but I think you get my drift...............
I'm having a hard time believing management could launch a rowboat into a calm lake on a perfect day, never mind during a thunderstorm. I to have employed the strategy unfortunately this time I got caught on the wrong side. Still can not believe how many opportunities management has blown over time. The product/idea/concept/device will survive the test of time and many patients will be better off , IMO.
Heck, maybe the IRS will allow a charitable contribution as well as a tax loss ?
oh contrare, they own all patents and assets when present management runs out of money and options...............................................at pennies on the dollar to boot.!!!!!!!!!!!
Q1, a few days ago, seemed to answer that, long , short or neutral MELA as an investment, most agreed with the concept and need for a device like Melafind. The FDA has agreed in principle and in fact by an approval of sorts. Management has and continues to be so narrow and unfocused , IMO , on the scale, scope and business opportunity at hand.
Why doesn't a deep pocketed company, investor grab the patents, assets for pocket change, dump management and create a full range business division or for that matter a stand alone company ? That in my opinion is the real question...........
All they did was bailout Broadfins position at the expense of current shareholders IMO. Where was/is the additional funds for operating expenses ?????
If I'm reading it correctly Mela is using the proceeds to buy out the pref. shares A series they issued in Feb for B shares now issued hence Broafin made whole and Mela shareholders are diluted even further, after fees and issue of shares what is left for operating capitol????.. Sure glad that management is looking out for the shareholders. Additionally, I think they get to keep the warrants issued for the remainder of the 5ys from 2/2014.
If I can buy a thermometer to take my temperature, Why can't I buy a Melafind to read a Mole ? A scaled down version of this device should be in every home like a toothbrush, thermometer, etc. and should be used daily or as needed to refer individual to seek professional help as needed. More sophisticated machines should be used by professionals, etc. etc, The amount of money involved staggers the imagination. Managements inability to capitalize is beyond belief. How long ago did the FDA grant approval and management still IMO doesn't have a business plan that any Business school student would need to submit to graduate.
A $13 million dollar market cap, hell you could make that in a weekend on the home shopping network. The real losers are those walking around with early stage melanomas and do not know it..................
this time in 16 is 2 years from now. believing in management getting it done on time? What needs to be accomplished is a revenue generating plan or we will see further dilution of this magnitude or worse before ins. reimbursement approval. With current cash and burn rate MELA has how long ?
7/21/14 5.21 shares outstanding as per yahoo.
7/22/14 Managements latest refi./ sale
1] debenture can convert to 5.8 m shares, collects 4% and gets patents [ intellectual property ] if foreclosed, can't wait to see wording/conditions.
2] pref.shares can convert to 4.8 m shares.
3] 11.2 m shares via warrants issued. 5m @ $2.5ish in 18months, 6.1m @$2.4ish in 5 years
4] total shares in play 21 million.
5] 21/5 or 4/1 warrants worthless 10/5 or 2/1
6] did I read the release correctly?
No revenues to speak of till insurance reimbursement [ 2-3 years out as per management ]. Someone, wink, wink, if you consider past fees and earned interest, future interest, profit from past shorting and warrant sales, etc. etc. will wind up with patents [ IP ] etcetera , at virtually no cost within a few years. Anyone know of a catalyst that presents a brighter outcome? As Bob said a few years back " When you ain't got nothing you got nothing to lose ". It looks to me that management took it literally ...................................................